Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.
Molla M WassieGraeme Paul YoungCharles CockPeter BamptonJean M WinterKalindra SimpsonHariti SalujaAnthony ChuangRobert J FraserErin Leigh SymondsPublished in: Journal of gastroenterology and hepatology (2022)
Surveillance colonoscopy can be safely extended beyond 6 months in elevated colorectal cancer risk patients who do not have prior advanced adenoma diagnosis, particularly if interval FIT is negative.